← Open Payments lookup

EMILY CRABTREE: Open Payments

NPI 1639525975 · LEBANON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,207 in 61 payments from 14 companies in 2025. Trend: 2023 $1,011 · 2024 $1,206 · 2025 $1,207

Food & beverage: $1,207
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$307
Neurocrine BioSciences, Inc.10$181
ABBVIE INC.16$168
Otsuka America Pharmaceutical, Inc.5$112
Novo Nordisk Inc5$96
GlaxoSmithKline, LLC.3$71
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$64
Janssen Pharmaceuticals, Inc3$53
Takeda Pharmaceuticals U.S.A., Inc.2$38
PFIZER INC.2$35

Products named: INGREZZA, AIRSUPRA, REXULTI, BREZTRI, VRAYLAR, TRELEGY ELLIPTA, FARXIGA, CAPLYTA.

Industry payments across VA — which companies pay providers there.